Sankaran Sid 4

What Happened
Sankaran Sid, a director of Oscar Health, received a grant of 858 deferred stock units (DSUs) on July 9, 2026. The units were valued using the closing price of OSCR Class A common stock on that date ($31.20), giving an aggregate value of approximately $26,770. This was an award (grant) issued in lieu of a cash board retainer and is reported as a derivative instrument.

Key Details

• Transaction date and terms: July 9, 2026 — 858 deferred stock units at $31.20 per unit (total ~$26,770). Transaction coded as an award/grant (derivative).
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnotes summary:
  • Each DSU represents a right to receive one share of Class A common stock (F1).
  • DSUs will be settled for cash or shares, at the company’s discretion, within 45 days of the first of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. DSUs issued in lieu of a cash retainer are 100% vested on the grant date (F2).
  • The reporting person elected DSUs instead of cash retainer under the company’s deferred compensation plan; the unit count was calculated using the July 9, 2026 closing price (F3).
• Filing timeliness: Reported on July 13, 2026 for a July 9 transaction; filing appears timely (filed within required two business days).

Context
Deferred stock units are a non-cash award that give the recipient a future right to receive shares or cash rather than an immediate open-market purchase or sale. Because these DSUs were issued in lieu of a cash retainer and are 100% vested on grant, they represent immediate economic value to the director but do not necessarily signal the director buying or selling shares based on market views.